SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-058066
Filing Date
2019-10-31
Accepted
2019-10-31 07:06:22
Documents
15
Period of Report
2019-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1921376-1_8k.htm   iXBRL 8-K 29646
2 EXHIBIT 99.1 tm1921376d1_ex99-1.htm EX-99.1 274724
3 GRAPHIC tm1921376d1_ex99-1img001.jpg GRAPHIC 5262
  Complete submission text file 0001104659-19-058066.txt   562084

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA irwd-20191031.xsd EX-101.SCH 3442
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE irwd-20191031_def.xml EX-101.DEF 26583
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20191031_lab.xml EX-101.LAB 36321
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20191031_pre.xml EX-101.PRE 25241
16 EXTRACTED XBRL INSTANCE DOCUMENT tm1921376-1_8k_htm.xml XML 4720
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 191182065
SIC: 2834 Pharmaceutical Preparations